可变剪接调控分子Tra2β介导衰老阶段中枢髓鞘再生障碍的作用及机制研究
批准号:
32100935
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
邵麒
依托单位:
学科分类:
衰老与生物节律
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
邵麒
中文摘要
大脑极易受到衰老的影响而发生退行性改变,其中髓鞘化神经纤维所受的影响较皮层灰质的更为严重。研究表明衰老是影响髓鞘再生效率最重要的因素之一,但衰老阶段由OPCs自身分化缺陷导致髓鞘再生障碍的发生机制尚未阐明。本课题预实验发现:①可变剪接调控分子Tra2β在中枢白质中的表达水平随着衰老逐渐下降,且主要在少突胶质谱系细胞中下调;②Tra2β可以明显地促进OPCs的体外、体内分化及髓鞘化;③诱导性条件性敲除Tra2β则会显著抑制LPC病灶中OPCs分化及再髓鞘化。拟将采用LPC脱髓鞘模型、条件性基因敲除小鼠、分子生物学等技术进一步检测Tra2β的下调是否介导了衰老对中枢髓鞘再生的抑制作用;其次,评估Tra2β过表达能否挽救衰老阶段中枢髓鞘再生障碍;最后,揭示Tra2β发挥作用的下游靶分子。这些研究为衰老阶段中枢髓鞘再生障碍提供了新的分子机制,并为脱髓鞘相关神经精神类疾病的治疗提供新思路和新靶点。
英文摘要
Brain is susceptible to degeneration associated with aging. In the brain, myelinated nerve fibers are more severely affected than cortical gray matter by aging. Studies had manifested that aging acted as one of the most significant factors affecting the efficiency of myelin regeneration. However, the underlying mechanism by which aging affects OPCs differentiation and remyelination is not fully understood yet. Our preliminary data have shown that:①The expression of Transformer 2 beta (Tra2β) was dramatically decreased in white matter during aging. The decline of Tra2β expression was mainly located in oligodendrocyte lineage cells. ②Tra2β was found to promote the differentiation and myelination of OPCs in vitro and in vivo. ③Significantly, the induced conditional deletion of Tra2β in OPCs remarkably inhibited OPCs differentiation and remyelination in LPC mice. Next, we aim to further clarify the effect of Tra2β down-regulation in mediating the inhibitory effect of aging on remyelination based on LPC induced demyelination models, conditional knockout mice, cellular and molecular biological technologies. Secondly, we will examine whether Tra2β overexpression could rescue the remyelination failure of aged CNS. Lastly, we will explore the molecular mechanism of Tra2β in regulating OPCs differentiation and remyelination in aged CNS. These studies will help elucidate the molecular mechanism of aging in affecting myelin regeneration, and provide a novel strategy and drug target for the therapy of demyelinating diseases.
中枢神经系统的髓鞘化是一个高度协调且受到精密调控的过程。来自于转录因子、组蛋白甲基化、组蛋白乙酰化、染色质重塑和非编码RNA的调控可以介导髓鞘基因表达的动态性。目前研究人员已经在转录水平和表观遗传水平基本上阐明了少突胶质细胞髓鞘化的调控机制。但是关于转录后水平的调控,仍有很多未解之谜,尤其是可变剪接调控方面。TRA2B作为可变剪接家族中重要一员,在神经系统中的功能尤其重要。研究报道Tra2b的变异能导致一种全新类型的神经发育障碍。这些携带Tra2b遗传变异的患者均表现为智力障碍和/或发育迟缓,常伴有自闭症谱系障碍及胼胝体发育不良、髓鞘化延迟等脑部结构异常。考虑到脑白质结构在大脑认知功能中扮演的重要角色,我们提出大胆的猜想:Tra2b遗传变异引发的胼胝体发育不良和髓鞘发育缺陷可能是这些患者出现智力障碍和/或自闭症谱系障碍的重要病理基础。. 利用在少突胶质谱系细胞中特异性敲除Tra2b的转基因小鼠,我们阐明了TRA2B在少突胶质细胞分化成熟和髓鞘发育过程中重要的且以前未被认识的细胞自主功能,以及在认知功能方面的调控作用。我们进一步利用三代全长测序和蛋白质组学分析发现:如果在少突胶质谱系细胞中特异性敲除Tra2b,会显著下调TRA2B与髓鞘蛋白基因不均一核RNA(pre-mRNAs)之间的结合。髓鞘蛋白基因的转录本会受到 Tra2b特异性敲除的影响而发生外显子跳跃,从而导致其表达水平出现下降,并最终导致髓鞘蛋白的表达量显著下调。总而言之,我们的研究首次证实了可变剪接调控蛋白TRA2B在中枢神经系统髓鞘发育中的重要调控作用,阐明了其调控少突胶质细胞的分化成熟和髓鞘化的细胞类型特异性的分子机制,还有希望能帮助我们更好地理解髓鞘发育缺陷与认知功能障碍之间的关联。
国内基金
海外基金